Literature DB >> 18248287

Transplantation of human bone marrow-derived stromal cells into the contused spinal cord of nude rats.

Rishi N Sheth1, Glen Manzano, Xiuming Li, Allan D Levi.   

Abstract

OBJECT: Human bone marrow stromal cells (hMSCs) constitute a potential source of pluripotent stem cells. In the present study, hMSCs were transplanted into an area of spinal cord contusion in nude rats to determine their survival, differentiation, potential for neuroprotection, and influence on axonal growth and functional recovery.
METHODS: Twenty-nine animals received 6 x 10(5) hMSCs in 6 microl medium 1 week after a contusion, while 14 control animals received an injection of 6 microl medium alone. Basso-Beattie-Bresnahan (BBB) tests were performed weekly. The spinal cords were collected at 6 weeks posttransplantation for histological analysis and assessment of tissue injury.
RESULTS: Immunostaining with anti-human mitochondria antibody and pretransplantation labeling with green fluorescent protein demonstrated that the grafted hMSCs survived and were capable of achieving a flattened appearance in the grafted area; however, none of the transplanted cells stained positively for human-specific neuronal, anti-neurofilament H or glial fibrillary acidic protein within the sites of engraftment. While neuronal or astrocytic differentiation was not seen, cells lining blood vessels in the vicinity of the transplant stained positively for anti-human endothelium CD105 antibody. Staining for anti-neurofilament H antibody demonstrated abundant axonlike structures around the transplanted area in the hMSC group. Tissue sparing analysis showed that animals with grafted hMSCs had a smaller area of contusion cyst compared with controls, but there was no significant difference between the two groups in BBB scores.
CONCLUSIONS: The grafted hMSCs survived for > or = 6 weeks posttransplantation, although they did not differentiate into neural or glial cells. Cells with human endothelial characteristics were observed. Spinal cord-injured rats grafted with hMSCs had smaller contusion cavities, which did not have a significant influence on functional recovery.

Entities:  

Mesh:

Year:  2008        PMID: 18248287     DOI: 10.3171/SPI/2008/8/2/153

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  16 in total

1.  Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells.

Authors:  Justine Allard; Ké Li; Xavier Moles Lopez; Stéphane Blanchard; Paul Barbot; Sandrine Rorive; Christine Decaestecker; Roland Pochet; Delphine Bohl; Angelo C Lepore; Isabelle Salmon; Charles Nicaise
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

2.  Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.

Authors:  Xiaoyun Xu; Nicole Geremia; Feng Bao; Anna Pniak; Melissa Rossoni; Arthur Brown
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

3.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 4.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

5.  Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury.

Authors:  Ying Jin; Birgit Neuhuber; Anita Singh; Julien Bouyer; Angelo Lepore; Joseph Bonner; Tim Himes; James T Campanelli; Itzhak Fischer
Journal:  J Neurotrauma       Date:  2011-03-24       Impact factor: 5.269

6.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury.

Authors:  Hideaki Nakajima; Kenzo Uchida; Alexander Rodriguez Guerrero; Shuji Watanabe; Daisuke Sugita; Naoto Takeura; Ai Yoshida; Guang Long; Karina T Wright; William E B Johnson; Hisatoshi Baba
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

Review 7.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.

Authors:  Sabina Luchetti; Kevin D Beck; Manuel D Galvan; Richard Silva; Brian J Cummings; Aileen J Anderson
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

9.  Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods.

Authors:  Courtney Paul; Amer F Samdani; Randal R Betz; Itzhak Fischer; Birgit Neuhuber
Journal:  Spine (Phila Pa 1976)       Date:  2009-02-15       Impact factor: 3.468

10.  Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury.

Authors:  Jason Sharp; Jennifer Frame; Monica Siegenthaler; Gabriel Nistor; Hans S Keirstead
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.